Active Ingredient(s):Hyaluronidase FDA Approved: * October 26, 2004 Pharm Company: *AMPHASTAR PHARM Category:Medical Device
Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). Karl Meyer classified these enzymes in 1971, into three distinct groups, a scheme based on the enzyme reaction products. The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.
In humans, there are five functional hyaluronidases: HYAL1, HYAL2, HYAL3, HYAL4 and HYAL5 (also known a...
* May have multiple approval dates, manufacturers, or labelers.